ANI Pharmaceuticals's market cap is currently $2.08B. The company's EPS TTM is $1.8; its P/E ratio is ―; ANI Pharmaceuticals is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is $1.71. See an overview of income statement, balance sheet, and cash flow financials.
